Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015, Article ID 791825, 7 pages
http://dx.doi.org/10.1155/2015/791825
Research Article

Pigment Epithelium-Derived Factor Induces Endothelial Barrier Dysfunction via p38/MAPK Phosphorylation

1Institute of Burn Research, Southwest Hospital, Third Military Medical University, State Key Laboratory of Trauma, Burns and Combined Injury, Chongqing Key Laboratory for Diseases Proteomics, Chongqing 400038, China
2Department of Endocrinology, Southwest Hospital, Third Military Medical University, Chongqing 400038, China

Received 23 January 2015; Accepted 12 March 2015

Academic Editor: Liliam Fernandes

Copyright © 2015 Ting He et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. B. E. Steinberg, N. M. Goldenberg, and W. L. Lee, “Do viral infections mimic bacterial sepsis? The role of microvascular permeability: a review of mechanisms and methods,” Antiviral Research, vol. 93, no. 1, pp. 2–15, 2012. View at Publisher · View at Google Scholar · View at Scopus
  2. D. Gulino-Debrac, “Mechanotransduction at the basis of endothelial barrier function,” Tissue Barriers, vol. 1, no. 2, Article ID e24180, 2013. View at Publisher · View at Google Scholar
  3. S. Weis, J. Cui, L. Barnes, and D. Cheresh, “Endothelial barrier disruption by VEGF-mediated Src activity potentiates tumor cell extravasation and metastasis,” The Journal of Cell Biology, vol. 167, no. 2, pp. 223–229, 2004. View at Publisher · View at Google Scholar · View at Scopus
  4. C. Sun, M. H. Wu, and S. Y. Yuan, “Nonmuscle myosin light-chain kinase deficiency attenuates atherosclerosis in apolipoprotein e-deficient mice via reduced endothelial barrier dysfunction and monocyte migration,” Circulation, vol. 124, no. 1, pp. 48–57, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. X. Peng, P. M. Hassoun, S. Sammani et al., “Protective effects of sphingosine 1-phosphate in murine endotoxin-induced inflammatory lung injury,” The American Journal of Respiratory and Critical Care Medicine, vol. 169, no. 11, pp. 1245–1251, 2004. View at Publisher · View at Google Scholar · View at Scopus
  6. J. V. Bonventre and L. Yang, “Cellular pathophysiology of ischemic acute kidney injury,” The Journal of Clinical Investigation, vol. 121, no. 11, pp. 4210–4221, 2011. View at Publisher · View at Google Scholar
  7. B. A. Wilkerson and K. M. Argraves, “The role of sphingosine-1-phosphate in endothelial barrier function,” Biochimica et Biophysica Acta, vol. 1841, no. 10, pp. 1403–1412, 2014. View at Publisher · View at Google Scholar
  8. N. Tahara, S.-I. Yamagishi, A. Tahara et al., “Serum level of pigment epithelium-derived factor is a marker of atherosclerosis in humans,” Atherosclerosis, vol. 219, no. 1, pp. 311–315, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. S. P. Becerra and V. Notario, “The effects of PEDF on cancer biology: mechanisms of action and therapeutic potential,” Nature Reviews Cancer, vol. 13, no. 4, pp. 258–271, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. J. Cai, Z. Chen, Q. Ruan et al., “γ-secretase and presenilin mediate cleavage and phosphorylation of vascular endothelial growth factor receptor-1,” The Journal of Biological Chemistry, vol. 286, no. 49, pp. 42514–42523, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. H. Hutchings, M. Maitre-Boube, J. Tombran-Tink, and J. Plouëta, “Pigment epithelium-derived factor exerts opposite effects on endothelial cells of different phenotypes,” Biochemical and Biophysical Research Communications, vol. 294, no. 4, pp. 764–769, 2002. View at Publisher · View at Google Scholar · View at Scopus
  12. T.-C. Ho, S.-L. Chen, Y.-C. Yang, C.-L. Liao, H.-C. Cheng, and Y.-P. Tsao, “PEDF induces p53-mediated apoptosis through PPAR gamma signaling in human umbilical vein endothelial cells,” Cardiovascular Research, vol. 76, no. 2, pp. 213–223, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. D. Chuderland, I. Ben-Ami, R. Kaplan-Kraicer, H. Grossman, R. Ron-El, and R. Shalgi, “The role of pigment epithelium-derived factor in the pathophysiology and treatment of ovarian hyperstimulation syndrome in mice,” Journal of Clinical Endocrinology and Metabolism, vol. 98, no. 2, pp. E258–E266, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. J. Wegener and J. Seebach, “Experimental tools to monitor the dynamics of endothelial barrier function: a survey of in vitro approaches,” Cell and Tissue Research, vol. 355, no. 3, pp. 485–514, 2014. View at Publisher · View at Google Scholar · View at Scopus
  15. J. Amado-Azevedo, E. T. Valent, and G. P. van Nieuw Amerongen, “Regulation of the endothelial barrier function: a filum granum of cellular forces, Rho-GTPase signaling and microenvironment,” Cell and Tissue Research, vol. 355, no. 3, pp. 557–576, 2014. View at Publisher · View at Google Scholar · View at Scopus
  16. T. Nelius, D. Martinez-Marin, J. Hirsch et al., “Pigment epithelium-derived factor expression prolongs survival and enhances the cytotoxicity of low-dose chemotherapy in castration-refractory prostate cancer,” Cell Death and Disease, vol. 5, no. 5, Article ID e1210, 2014. View at Publisher · View at Google Scholar · View at Scopus
  17. J. Cai, L. Wu, X. Qi et al., “PEDF regulates vascular permeability by a γ-secretase-mediated pathway,” PLoS ONE, vol. 6, no. 6, Article ID e21164, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. A. J. Jenkins, S. X. Zhang, K. G. Rowley et al., “Increased serum pigment epithelium-derived factor is associated with microvascular complications, vascular stiffness and inflammation in Type 1 diabetes1,” Diabetic Medicine, vol. 24, no. 12, pp. 1345–1351, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. A. Konson, S. Pradeep, C. W. D'Acunto, and R. Seger, “Pigment epithelium-derived factor and its phosphomimetic mutant induce JNK-dependent apoptosis and p38-mediated migration arrest,” The Journal of Biological Chemistry, vol. 286, no. 5, pp. 3540–3551, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. J. Yang, E. J. Duh, R. B. Caldwell, and M. Ali Behzadian, “Antipermeability function of PEDF involves blockade of the MAP kinase/GSK/β-catenin signaling pathway and uPAR expression,” Investigative Ophthalmology and Visual Science, vol. 51, no. 6, pp. 3273–3280, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. L. Chen, S. S.-M. Zhang, C. J. Barnstable, and J. Tombran-Tink, “PEDF induces apoptosis in human endothelial cells by activating p38 MAP kinase dependent cleavage of multiple caspases,” Biochemical and Biophysical Research Communications, vol. 348, no. 4, pp. 1288–1295, 2006. View at Publisher · View at Google Scholar · View at Scopus
  22. Y. Yang, S. C. Kim, T. Yu et al., “Functional roles of p38 mitogen-activated protein kinase in macrophage-mediated inflammatory responses,” Mediators of Inflammation, vol. 2014, Article ID 352371, 13 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  23. H. K. Koul, M. Pal, and S. Koul, “Role of p38 MAP kinase signal transduction in solid tumors,” Genes and Cancer, vol. 4, no. 9-10, pp. 342–359, 2013. View at Publisher · View at Google Scholar · View at Scopus
  24. P. V. Usatyuk, S. Vepa, T. Watkins, D. He, N. L. Parinandi, and V. Natarajan, “Redox regulation of reactive oxygen species-induced p38 MAP kinase activation and barrier dysfunction in lung microvascular endothelial cells,” Antioxidants & Redox Signaling, vol. 5, no. 6, pp. 723–730, 2003. View at Publisher · View at Google Scholar · View at Scopus
  25. P. Geraldes, M. G. Sirois, P. N. Bernatchez, and J.-F. Tanguay, “Estrogen regulation of endothelial and smooth muscle cell migration and proliferation: role of p38 and p42/44 mitogen-activated protein kinase,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 22, no. 10, pp. 1585–1590, 2002. View at Publisher · View at Google Scholar · View at Scopus
  26. Z. G. Chu, J. P. Zhang, H. P. Song et al., “P38 map kinase mediates burn serum-induced endothelial barrier dysfunction: involvement of F-actin rearrangement and L-caldesmon phosphorylation,” Shock, vol. 34, no. 3, pp. 222–228, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. J.-Y. Hu, Z.-G. Chu, J. Han et al., “The p38/MAPK pathway regulates microtubule polymerization through phosphorylation of MAP4 and Op18 in hypoxic cells,” Cellular and Molecular Life Sciences, vol. 67, no. 2, pp. 321–333, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. J. Shi, J. Guan, B. Jiang et al., “Amyloidogenic light chains induce cardiomyocyte contractile dysfunction and apoptosis via a non-canonical p38α MAPK pathway,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 9, pp. 4188–4193, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. L. S. Rodgers and A. S. Fanning, “Regulation of epithelial permeability by the actin cytoskeleton,” Cytoskeleton (Hoboken), vol. 68, no. 12, pp. 653–660, 2011. View at Publisher · View at Google Scholar · View at Scopus
  30. X. Tian, Y. Tian, N. Sarich, T. Wu, and A. A. Birukova, “Novel role of stathmin in microtubule-dependent control of endothelial permeability,” The FASEB Journal, vol. 26, no. 9, pp. 3862–3874, 2012. View at Publisher · View at Google Scholar · View at Scopus